In NSG-AD mice, the challenge with DMSO seemed to have led to a more pronounced influx of CD4+ and CD8+ T cells, CD14+ monocytes, and CD19+ B cells than challenged NSG-PV mice (Figure 4). The gene discussed is CD19; the disease is Alzheimer disease.